Active Ingredient(s):Interferon Beta-1a FDA Approved: * May 17, 1996 Pharm Company: *BIOGEN Category:Multiple Sclerosis
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses.
Interferon beta has not been shown to slow the advance of disability.[9...
* May have multiple approval dates, manufacturers, or labelers. 6 Discussions